TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 11 | 0 | -0 | 0 | 6 | 8 | 23 | 6 |
| S | %wins | 73 | 73 | 64 | 45 | 9 | 27 | 48 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/22 20:00 | 3/9/22 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.m | -5,087 | 10.17 | 0 | -500 | -32 | 1,062 | I | ||||||||||||||
3/6/18 20:10 | 3/2/18 | MYL | Mylan N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Coury Robert J | X0 | D | S.m | -8,185 | 40.93 | 0 | -200 | -14 | 1,266 | I | |||||||||||||||
4/7/16 21:05 | 4/5/16 | MYL | Mylan N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Coury Robert J | X0 | DO | Exec CB | S | -10,007 | 45.96 | 33 | -218 | -14 | 1,339 | D | -5 | -19 | 10 | -11 | 4 | 4 | 7 | 2 | -2 | -2 | -14 | -9 | -21 | -19 |
2/3/15 21:00 | 1/30/15 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.dm | -49,770 | 52.55 | 33 | -947 | -42 | 1,282 | D | 88 | 17 | 8 | 2 | -6 | -4 | -2 | -4 | -3 | -3 | 2 | 35 | 1 | -7 |
11/26/14 18:01 | 11/24/14 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.dm | -9,243 | 55.78 | 33 | -166 | -13 | 1,077 | D | 108 | 27 | 13 | 17 | 19 | 5 | 4 | 2 | 0 | -1 | -2 | -2 | 25 | -12 |
12/13/13 19:30 | 12/11/13 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S | -6,220 | 41.62 | 33 | -149 | -14 | 938 | D | 109 | 50 | 32 | 8 | 11 | -1 | -3 | -5 | 0 | 2 | 11 | 28 | 21 | 28 |
12/17/12 21:03 | 12/13/12 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.dm | -53,658 | 28.00 | 33 | -1,916 | -67 | 940 | D | 35 | 40 | 33 | 15 | 9 | 4 | 3 | 0 | 0 | -1 | 0 | 9 | 13 | 49 |
10/26/12 17:32 | 10/26/12 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.d | -17,015 | 25.21 | 33 | -675 | -42 | 940 | D | 23 | 28 | 13 | 7 | 3 | 2 | 4 | 6 | 0 | 2 | 8 | 12 | 14 | 54 |
5/15/12 17:07 | 5/15/12 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.d | -1,957 | 21.30 | 33 | -92 | -9 | 940 | D | 4 | -11 | 17 | -7 | -9 | -2 | 1 | 4 | 0 | 0 | -2 | 11 | 23 | 44 |
4/16/12 16:59 | 4/16/12 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.d | -3,312 | 22.08 | 33 | -150 | -14 | 940 | D | 0 | -6 | 22 | -1 | -5 | -4 | -6 | 3 | 3 | -1 | -3 | 0 | 8 | 27 |
3/15/12 17:04 | 3/15/12 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.d | -3,447 | 22.98 | 33 | -150 | -15 | 835 | D | 3 | 4 | 12 | 13 | 3 | -4 | 0 | -1 | 0 | 0 | -4 | -9 | 4 | 34 |
2/15/12 17:17 | 2/15/12 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.d | -3,488 | 23.25 | 33 | -150 | -16 | 787 | D | 24 | -1 | 17 | 24 | 5 | 10 | 4 | 1 | 2 | 1 | -1 | -8 | 1 | 26 |
1/17/12 16:58 | 1/17/12 | MYL | Mylan Inc. | PA | Health | Drug | Pharmaceutical Preparations | Coury Robert J | PA | DO | Exec CB | S.d | -3,257 | 21.71 | 33 | -150 | -16 | 787 | D | 21 | -4 | -8 | 21 | 10 | 1 | 0 | -2 | 1 | 0 | 8 | 2 | 2 | 30 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |